Using personal digital assistants to document pharmacist cognitive services and estimate potential reimbursement

American Journal of Health-System Pharmacy

Volumn 60, Issue 9, 2003, Pages 911-915

  Silva, Matthew A ^a   Tataronis, Gary R ^b   Maas, Barbara ^c  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b MCP   (United States)

^c University of Massachusetts   (United States)

Author keywords

Computers; Documentation; Interventions; Pharmaceutical services; Pharmacists; Reimbursement

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIINFECTIVE AGENT; SEDATIVE AGENT;

ARTICLE; CLINICAL PHARMACY; COGNITION; COST EFFECTIVENESS ANALYSIS; DATA BASE; DIGITAL COMPUTER; DOCUMENTATION; DRUG ADMINISTRATION ROUTE; DRUG HYPERSENSITIVITY; DRUG INFORMATION; HOSPITAL PATIENT; INFORMATION PROCESSING; INTENSIVE CARE UNIT; MEDICAID; PAIN; PARENTERAL NUTRITION; PERSONAL DIGITAL ASSISTANT; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; REIMBURSEMENT; RESIDENCY EDUCATION; SEDATION;

EID: 0038308335     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.9.911     Document Type: Article

References (22)

1. Gandhi PJ, Smith BS, Tataronis GR et al. Impact of a pharmacist on drug costs in a coronary care unit. Am J Health-Syst Pharm. 2001; 58:497-503.
2. Follin SL, Kwong NM. Enhancement of a pharmacy consultation program on a transitional care unit. Am J Health-Syst Pharm. 2000; 57:1990-3.
3. Skedlar SJ, Hess MM. Implementation of a drug-use and disease-state management program. Am J Health-Syst Pharm. 2000; 57(suppl 4):S23-9.
4. Bozek PS, Perdue BE, Bar-Din M et al. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health-Syst Pharm. 1998; 55:1151-5.
5. Brophy GM, Tesoro EP, Schrote GL et al. Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury. Pharmacotherapy. 2002; 22:251-5.
6. Chisholm MA, Vollenweider LJ, Mulloy LL et al. Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic. Clin Transpl. 2000; 14(4, pt. 1):304-7.
7. Barenfanger J, Short MA, Groesch AA. Improved antimicrobial interventions have benefits. J Clin Microbiol. 2001; 39:2823-8.
8. Dager WE, Branch JM, King JH et al. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother. 2000; 34:567-72.
9. Gums JG, Yancey RW Jr, Hamilton CA et al. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999; 19:1369-77.
10. McMullin ST, Hennenfent JA, Ritchie DJ et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999; 159:2306-9.
11. Ariano RE, Demianczuk RH, Danzinger RG et al. Economic impact and clinical benefits of pharmacist involvement on surgical wards. Can J Hosp Pharm. 1995; 48:284-9.
12. Condron JH, Mann JL. Drug utilization and therapeutic intervention programs: pharmacy services that pay for themselves. Can J Hosp Pharm. 1994; 47:203-8.
13. Chuang LC, Sutton JD, Henderson GT. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit. Hosp Pharm. 1994; 29:215-8,221.
14. Torok N, Brown G. The economic impact of clinical pharmacists' unsolicited recommendations. Hosp Pharm. 1992; 27:1052-3,1056-8.
15. Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs medical center. Pharmacotherapy. 1998; 18:1103-11.
16. Mutnick AH, Sterba KJ, Peroutka JA et al. Cost savings and avoidance from clinical interventions. Am J Health Syst-Pharm. 1997; 54:392-6.
17. Benrimoj SI, Langford JH, Berry G et al. Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowance. Pharmacoeconomics. 2000; 18:459-68.
18. Keely JL. Pharmacist scope of practice. Ann Intern Med. 2002; 136:79-85.
19. Reilly JC, Wallace M, Campbell MM. Tracking pharmacist interventions with a hand-held computer. Am J Health-Syst Pharm. 2001; 58:158-61.
20. Lau A, Balen RM, Lam R et al. Using a personal digital assistant to document clinical pharmacy services in an intensive care unit. Am J Health-Syst Pharm. 2001; 58:1229-32.
21. Brody JA, Camamo JM, Maloney ME. Implementing a personal digital assistant to document clinical interventions by pharmacy residents. Am J Health-Syst Pharm. 2001; 58:1520-2.
22. Landrum-Michalets E, Williams E. Reimbursement for pharmacists' cognitive services in the inpatient setting. Am J Health-Syst Pharm. 2001; 58:164-6.